Healthcare Research & Advisory
We are a preferred partner to healthcare industry investors and other corporate leaders to help them make better investment decision and create value
How we can help?
Medical Devices and Technologies
Aranca provides actionable intelligence and advisory to medical technology companies on products, innovation and growth areas, collaboration opportunities, and business planning to aid decision making
Medical Devices and Technologies
Aranca provides actionable intelligence and advisory to medical technology companies on products, innovation and growth areas, collaboration opportunities, and business planning to aid decision making
Aranca helps clients in critical decision making across the product life cycle from Research to Commercialization and Lifecycle Management activities. Through an ideal mix of secondary and primary research and expertise in the pharmaceutical sector that spans across different therapeutic areas and geographies, we offer services for Disease Landscape Assessment, Competitive Intelligence, Patient Journey Assessment, Stakeholder insights, Pricing and Market Access, Commercial Opportunity Assessment, Brand Strategy and Communication, Real World Evidence Studies and Due Diligence Support for Mergers and Acquisitions.
For entry into a new therapeutic area, assessing the market opportunity and unmet needs in the market is quintessential. Through expertise across different therapeutic areas, the team at Aranca can provide you meaningful insights to simplify your decision making process. Through our expertise in the pathophysiology of the disease combined with the epidemiology, market assessment and primary discussions with key stakeholders, we assist in market sizing, gauging the unmet need in the market and understanding the market trends. Disease Landscape Assessment / Development of Situational Analysis will provide you a current as well as futuristic picture of the market and help in estimating the opportunity.
Strategic evaluation of competitors' approach and capabilities, including a comprehensive study of both inline and pipeline products and competitor tracking through extensive secondary and primary research, is one of Aranca’s core expertise. Competitor pipeline assessment, patent analysis and clinical trial analysis help to give an overview of the competitive intensity of the market and the unmet need. Competitive Intelligence helps in not only designing internal strategies to stay relevant and profitable in the market, but also preparing for the future.
Key stakeholders in the Pharmaceutical Industry – Patients, Payers and Providers – remain pivotal for gaining first-hand insights on the market, unmet needs and product positioning, and to answer specific business questions related to product performance and benefits. Accessing insights from KOLs and clinicians to gauge their therapy preferences and challenges; from patients to understand their unmet needs; and from payers to understand the pricing and access scenarios are the solutions that Aranca offers regularly. With access to third-party patient and HCP panels as well as an inhouse team that is trained in primary discussions, we can provide you with valuable, qualitative and actionable insights.
Benchmarking Pricing Strategies, Cost Benefit Analysis, Analysis of the Reimbursement Scenario and HTAs are crucial for making decisions on the pricing of drugs to ensure a wide access of the drugs to patients. With the evolution of Health Economics and Outcomes Research, pricing decisions are now dependent on the value that the drug brings to the market. Evaluating new pricing and market access models, assessing market scenarios and unmet needs should be done early in the product development stage to ensure wide access and reimbursement for the drug.
Real world data on the usage, benefits and risks / adverse effects associated with the drug plays a crucial role not only in the post-marketing surveillance studies, but also in indication expansion for specific diseases / subpopulations. Real-world evidence gathered through third-party databases are analysed to provide insights on product performance, unmet needs and cost benefit ratio.
Assessment of the Patient, Payer and Provider landscape helps in developing the unique Value Proposition / Target Product Profile (TPP) of a drug in the developmental stage. Development of the patient journey and key stakeholder analysis to identify the unmet needs; competitive intelligence to evaluate relative product benefits; and corroboration of data with the internal preclinical data helps to establish a value proposition. Building scenarios around the TPP by evaluating the prescriber preference and uptake in the market during product launch is crucial for forecasting the commercial opportunity.
Communication in recent years has moved from mere disease / drug awareness to education, which is actively reshaping attitudes and beliefs for new products. Aranca works closely with clients for identifying customer segments and developing unique positioning and identity for the brand through extensive primary research. Aranca helps in highlighting key USPs and carving a differentiator in the market through a robust brand strategy and communication plan that resonates with key stakeholders to ensure a top-of-the-mind recall. Aranca also designs campaigns, activities and promotional messages that are measurable and can be implemented easily.
Product Lifecycle Management has become critical to continue being on the top of the game and constantly innovate to retain market share. Aranca help’s clients study the market pulse post-commercialization, and helps design strategies to maximise product profitability through new market assessment; new indication assessment and loss of exclusivity strategies for business expansion; and mitigation of loss caused by entry of generics
Success of a drug is vastly based on pre-empting the market dynamics and being ready to face contingencies through informed decision making and thorough study. Aranca helps with the development of business cases / forecasting models by market sizing built on concrete assumptions of competitor impact, product uptake and peak share through primary and secondary research. Analog analysis and attribute analysis are used to estimate the product uptake and peak share. Impact of LOE, other market access and conversion parameters are further considered to forecast the sales, along with Sensitivity and Scenario analysis to estimate the potential downside and upside of the business case.
Aranca works closely with clients to help identify partners based on mutual synergies and strength. Based on the strategic focus of the company, we work closely with clients to identify gaps in portfolio and future focus areas. We help in the identification and evaluation of partners with similar strategic focus for in licensing / out licensing partnerships for New Chemical Entities (NCEs) and formulations for exploring new market opportunities and optimising resources to fill portfolio gaps.
Finding the right partner for growth and diversification is critical to business decisions. Aranca supports clients with in-depth profiling of target companies to gain insights into their capabilities and product portfolio, and for evaluating them to determine a strategic fit. We also facilitate preliminary discussions with the target company to gauge the interest in the deal and facilitate the introduction of the client with the target company.
Business leaders across functional areas leverage our experience and expertise for diverse strategic and tactical priorities
We are experts in analyzing the external ecosystem to support growth and corporate development initiatives of medical technology companies
Our 360o business planning framework aids companies in taking actionable steps for creating long-term growth plan
Aranca follows a 4-by-5 strategy development framework for business planning consulting engagements
Our MI-CI offerings address the growing intelligence needs across functional areas of an enterprise
Co-sourced CI/MI Teams
Dedicated analyst(s) to support ongoing intelligence needs on competition, customers, new ideas, end-markets, etc.
Research Help
Desk
Cloud-based platform to support quick turnaround research requests from managers across functions and global offices
Knowledge
Portals
Design and maintenance of customized self-service information portals that support day-to-day business actions
Outsource routine knowledge tasks
Transfer heavy-lifting work that require human intervention to Aranca e.g. basic analytics, MIS reports, media monitoring
- Sectoral trends and analysis
- Business and operating models
- Best practices and case studies
- Product and Price Benchmarking
- Competitor Profiling
- Performance Tracking
- Prospect Profiles & Updates
- Proposal Development Support
- Whitepaper, Client Newsletters
Our M&A solution offerings span across the pre transaction and execution phases of the M&A transaction process
We also have wide expertise in providing research support and survey-based insights across product development and customer engagement lifecycle
Aranca’s custom feasibility studies are geared towards evaluation of market & financial metrics to inform viability of new projects and ventures
Opportunity Assessment
Our market feasibility studies analyze pertinent market and competitive dynamics in detail, to quantify latent whitespace, addressable scale of the opportunity and market viability of a proposed project. These include:
|
|
Financial Model & Valuation
We also specialize in assessing the financial feasibility of proposed projects and ventures by building robust financial models and running simulations to determine financial returns under different scenarios. Our financial models and analysis encapsulates:
|
Our market analysis and business planning solutions aids healthcare companies in taking actionable steps for creating long-term growth plan
perspectives
THOUGHT LEADERSHIP
Our Pharma team actively contributes with expert opinions and insights on the Pharma sector, covering a broad range of topics including sector outlook, new trends and their impact, opportunities in the sector and industry best practices.
Featured case studies
Go-to-Market for an Asian food & nutrition company to expand into liver disease medical foods in the US
Our Approach
- Review of scientific literature; sourcing of industry information
- 15+ interviews with healthcare professionals to assess the demand dynamics
- 20+ interviews with competitors to benchmark capabilities and strategies
- Roadmap to build commercial capabilities for market entry
IMPACT
Our fact-based analysis and recommendations enabled the Client to develop a marketing plan & open negotiations with key partners in pursuit of building their commercial capabilities in the US.
Unmet Need Assessment for a rare autoimmune indication
Our Approach
- Assessment of the disease epidemiology and treatment landscape
- In depth analysis of the patient segmentation and patient journey
- Competitive assessment of the pipeline as well as the marketed therapies
- Key stakeholder assessment to identify the unmet needs
IMPACT
Our findings enabled the Client to develop an in depth understanding of the rare disease and identify key unmet needs in the market
Evaluation of clinical trials for drugs used in selected immune – dermatological indications
Our Approach
- Evaluation of clinical pipeline of the indications
- Evaluation of the trial design and the results of the key clinical endpoints
- Insights on success factors and reasons for trial failures
- Overview of the treatment guidelines, standard of care and unmet need
IMPACT
Our findings enabled the Client to develop the clinical trial protocol for their early stage asset and helped them to do a inter asset and intra asset comparison of key clinical endpoints of the drugs
Market assessment of Efavirenz (EFV) API in India for a leading European specialty chemicals supplier
Our Approach
- Discussions with heads of various API manufacturers and WHO executives
- Analyzed production and trade data to ascertain market dynamics
- Reviewed regulatory policies and their impact on demand
- Assessed plans of major pharma companies to estimate future demand
IMPACT
Our analysis helped the Client to understand evolving market trends; additionally, the fact-based insights enabled them to strategically position themselves to supply DEZ used in synthesis of EFV.
Vaccine Schedules & Concomitancy Research in Dengue Endemic Markets for a Japanese pharma company
Our Approach
- Identified the type of vaccines and coverage by specified age group
- Segregated data for expanded program on immunization & private market
- Estimated potential demand across the age groups in the private market
- Assessed market share of leading players in the private market
IMPACT
Our analysis of leading vaccines in the pre-specified age segments for the private market enabled the Client to identify potential markets for their future dengue vaccine.
Market and competitor intelligence on Systemic Lupus Erythematosus in the US, EU, and Japanese markets
Our Approach
- Patient ecosystem analysis covering incidence, prevalence, disease burden
- Analyzed marketed drugs, drug failures and reasons for failure
- Drug pipeline overview covering alias/brand name, dosages & key claims
- Also, mechanism of action and route of administration were analyzed
IMPACT
Our research provided the client with insights on competitors products, strategies and plans, and enabled them to design clinical trial end points for their drug
Impact of connected home use drug-delivery devices on healthcare ecosystem for a global biotechnology company
Our Approach
- Review of secondary and commercial sources to analyze market dynamics
- Detailed discussions with 30 -35 market participants
- Use cases around connected home use drug-delivery solutions
- Assessed measurable business impact on pharma companies
IMPACT
Our insights on the quantifiable impact of connected home use drug-delivery devices enabled the client to plan budget allocation and chalk out a product development strategy
Assessing the market opportunity of Single-use Fluid Management Systems in the bioprocessing industry
Our Approach
- Review of market data from secondary and commercial sources
- Discussions with 15-20 industry experts and market participants
- Assessed access models, profitability and growth potential
- Framework to identify companies to target for expanding the US business
IMPACT
Insights provided by Aranca enabled the client to identify growth opportunities across single use product categories, and devise a roadmap to capitalize on these opportunities
Evaluating the clinical usage of 30ml syringes across acute care hospitals in the US for a global medical technology company
Our Approach
- In-depth discussions with nurses and pharmacists across 25 hospitals
- Captured data on usage, customer perception & preferences
- Synthesis of data to estimate market demand
- Evaluated the impact of switching syringe sizes on delivery of care
IMPACT
Our research insights enabled the client to identify hospital segments within acute care, generating higher demand, and development of an appropriate product and marketing strategy
Entry strategy in the European Glaucoma Drainage Devices (GDD) market for a global medical devices company
Our Approach
- Desk research to assess disease prevalence and treatment landscape
- Mapped and benchmarked product features of competitors
- Primary research covering ~65 respondents across the value chain
- Synthesis of data to analyze market dynamics and growth opportunity
IMPACT
The market insights and strategic roadmap for market entry was a key input for the Client being able to develop a growth strategy in the region for their GDD product line
Analysis of pen injector needles market in EU, US and APAC for a Swiss automation systems and solutions company
Our Approach
- 25 primary research interviews to assess market & technology trends
- Estimated market size and growth opportunities
- Analyzed role of key participants and margins in the value chain,
- Evaluated competitive intensity and benchmarking strategies of incumbents
IMPACT
Our analysis equipped the client with all the pertinent market intelligence required to make an informed decision on their short-to-medium term market strategy in the focus regions
Assessing opportunity in the US medical tubing market for a South Asian company as a part of their diversification strategy
Our Approach
- ~35 primary discussions with suppliers, end-users and industry experts
- Estimated market size (value and volume) and segmentation
- Analyzed market and technological trends driving development of the market
- Supply-side assessment to analyze commercial capabilities & business plans
IMPACT
Our analysis helped the Client understand the market dynamics and identify opportunities in the US, along with charting out a detailed go-to-market strategy
Supplier Benchmarking for Medical Device Design and Engineering Services
Our Approach
- Developed an exhaustive list of medium size and large companies
- Connected with 100+ suppliers to understand their capabilities
- Assessed the supplier capabilities to evaluate their fitment
- Recommended best-in-class suppliers
IMPACT
Our analysis facilitated the Client in complementing their internal technical and engineering capabilities by identifying and partnering with external firms
CLIENT TESTIMONIALS
A leading Belgium based Pharmaceutical company
“I wanted to thank you very much for all the work done over the past weeks. Feedback after the session was great, and I must say I learned a lot going through this summarized deck. It helped a lot to structure our thinking. Very well done.”
A leading American Multinational Consumer Goods Corporation
“Delivered work was spot on and presented great value versus investment.”
A leading Belgium based Pharmaceutical company
“The additions look great and the patient funnels in particular look like they will be immensely helpful for our commercial evaluation!”
Talk To Us
We will connect you to the right professional within our Healthcare Research & Advisory Team
Company
Services
Knowledge Library
Contact Us
© , Aranca. All rights reserved.
United States | United Kingdom | China | India | Dubai | KSA | Japan